The full document isn't yet available to us from the patent office.


The present invention relates to modulating extracellular protein degradation and/or protein clearance by modulating the cross-beta structure formation or tissue plasminogen activator-like activity, treatment of amyloidosis-type diseases by modulating the cross-beta structure, and diagnosis of amyloidosis-type diseases by visualising cross-beta structure.


Information currently unavailable.

CPC Classifications
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Oct 8, 2008
  • Application: Jul 8, 2003
    EP EP 08153132 A
  • Priority: Jul 8, 2003
    EP EP 03762927 A
  • Priority: Jul 8, 2003
    EP EP 08153132 A
  • Priority: Jul 9, 2002
    EP EP 02077797 A

Download Citation

Sign in to the Lens